Announcements Trials
Browse Landscape

Phase

Phase 2/3 3Phase NA 1Phase 3 1Phase 2 1

Status

Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colonic Neoplasms 3Urinary Bladder Neoplasms 1Nasopharyngeal Carcinoma 1Epstein-Barr Virus Infections 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 7Fluorouracil 6Leucovorin 5Bevacizumab 4Watchful Waiting 3Capecitabine 3XELOX 2Neoadjuvant Therapy 2Irinotecan 2Indocyanine Green 2Chemotherapy, Adjuvant 2Cetuximab 2sulindac sulfone 1pembrolizumab 1encorafenib 1dehydroftorafur 1cyclopropapyrroloindole 1Tranexamic Acid 1Standard of Care 1Sentinel Lymph Node Biopsy 1Radiofrequency Ablation 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Panitumumab 1Observation 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Iohexol 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Colonic Neoplasms × Watchful Waiting × Clear all
NCT05710406 2026-01-26

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Active not recruiting
1 enrolled
Gastrointestinal

Colonic Neoplasms

NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

NRG Oncology

Phase 2/3 Active not recruiting
635 enrolled 9 charts
Gastrointestinal

Colonic Neoplasms

NCT01097265 2013-08-12

Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2/3 Unknown
1,500 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡